子宫颈发育不良市场：依诊断类型、最终使用者、地区

子宫颈发育不良市场规模预计将从 2023 年的 6.75 亿美元增至 2030 年的 11.054 亿美元，预测期内年复合成长率(CAGR)为 7.3%。

图 1. 2023 年子宫颈发育不良市场占有率(%)（按地区）

子宫颈发育不良是子宫颈内壁（子宫入口）细胞的癌前变化。这些变化是透过对骨盆检查期间从子宫颈采集的细胞样本进行显微镜分析来检测的。鳞状上皮内病变是从子宫颈细胞抹片中观察到的子宫颈发育不良的病理学术语。子宫颈发育不良是由人类乳突病毒（HPV）感染引起的。 HPV 是一种非常常见的感染疾病，透过性接触传染。大多数新的 HPV 感染发生在年轻女性（15 至 25 岁）。大多数 HPV感染疾病没有任何症状并会自行消失。

市场动态：

主要市场参与者增加有机策略预计将在预测期内推动市场成长。例如，2021 年 3 月 1 日，专注于将精确设计的去氧核糖核酸（DNA）药物推向市场，用于治疗和预防感染疾病、癌症和 HPV 相关疾病的生物技术公司 Inovio 宣布 REVEAL 宣布在一项研究中所有可评估受试者均实现了主要和次要终点。本研究使用我们专有的 CELLECTRA 5PSP 设备评估了 VGX-3100 对与 HPV-16/18 相关的子宫颈恶性鳞状上皮内病变(HSIL) 的安全性、耐受性和有效性。它是两项正在进行的、关键的、随机的、双盲、多中心、安慰剂对照 3 期试验评估

目录

第一章 研究目的与前提

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
• 政府加大力度
• 子宫颈发育不良的盛行率在全球范围内不断增加
  • 抑制因素
• 开发中国家缺乏认识
  • 机会
• 政府资助增加
• 主要亮点
• 监管场景
• 最近的趋势
• 产品发布/核准
• PEST分析
• 波特的分析
• 合併、收购和合作

第四章子宫颈发育不良市场－冠状病毒（COVID-19）大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第五章子宫颈发育不良市场，依诊断类型，2018-2030

• 诊断测试
• HPV检测
• 子宫颈抹片检查
• 切片检查测试
• 诊断设备
• 阴道镜检查

第 6 章 子宫颈发育不良市场，依最终使用者划分，2018-2030 年

• 医院
• 诊断中心
• 门诊手术中心

第七章子宫颈发育不良市场，依地区，2018-2030

• 北美洲
• 美国
• 加拿大
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• ASEAN
• 韩国
• 其他亚太地区
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 南非
• 北非
• 中部非洲

第八章 竞争形势

• 公司简介
  • Roche
  • Qiagen
  • Abbott Laboratories
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical

第9章 章节

• 参考
• 调查方法
• 关于出版商

The Cervical Dysplasia Market size is expected to reach US$ 1,105.4 Mn by 2030, from US$ 675 Mn in 2023, exhibiting a compound annual growth rate (CAGR) of 7.3% during the forecast period.

Figure 1. Cervical Dysplasia Market Share (%), By Region, 2023

Cervical dysplasia is precancerous changes of the cells that make up the lining of the cervix, the opening to the womb (uterus). These changes are detected by microscopic analysis of cell samples which are taken from the cervix during a pelvic exam. Squamous intraepithelial lesion is the pathology term that is used to refer to cervical dysplasia which is observed in smears of cells taken from the cervix. Cervical dysplasia is caused by infection with the human papillomavirus (HPV). HPV is a very common infection that is transmitted through sexual contact. Most new HPV infections occur in young (ages 15-25) women. Most HPV infections do not produce any symptoms and resolve spontaneously.

Market Dynamics:

Increasing organic strategies by the key market players is expected to drive the market growth over the forecast period. For instance, on March 1, 2021, INOVIO, a biotechnology company focused on bringing to market precisely designed deoxyribonucleic acid (DNA)medicines to treat and protect people from infectious diseases, cancer and HPV-associated diseases, announced that it met primary and secondary endpoints among all evaluable subjects for the REVEAL 1 trial. This trial is one of two ongoing pivotal, randomized, double-blind, multi-center, placebo-controlled, Phase 3 trials evaluating the safety, tolerability, and efficacy of VGX-3100 to treat HPV-16/18-associated cervical high-grade squamous intraepithelial lesions (HSIL) using the company's proprietary CELLECTRA 5PSP device.

Cervical Dysplasia Market Detailed Segmentation:

• By Diagnosis Type
  • Diagnosis Test
  • HPV Test
  • Pap Smear Test
  • Biopsy Test
  • Diagnostic Device
  • Colposcope
• By End User
  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Top Companies in Cervical Dysplasia Market:
  • Roche
  • Qiagen
  • Abbott Laboratories
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Diagnosis Type
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing government initiatives
• Growing prevalence of cervical dysplasia globally
  • Restraints
• Lack of awareness in developing nations
  • Opportunities
• Increasing government funding
• Key Highlights
• Regulatory Scenario
• Recent Trends
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Mergers, Acquisitions and Collaborations

4. Cervical Dysplasia Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Cervical Dysplasia Market, By Diagnosis Type, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Diagnosis Test
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• HPV Test
• Pap Smear Test
• Biopsy Test
• Diagnostic Device
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Colposcope

6. Cervical Dysplasia Market, By End User, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, 2023and 2030 (%)
  • Y-o-Y Growth Analysis, 2019- 2030
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)
• Ambulatory Surgery Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Mn)

7. Cervical Dysplasia Market, By Region, 2018-2030, (US$ Mn)

• Introduction
  • Market Share Analysis, By Region, 2023and 2030 (%)
  • Y-o-Y Growth Analysis, For Region, 2019-2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• China
• Japan
• India
• Australia
• ASEAN
• South Korea
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Mn)
• South Africa
• North Africa
• Central Africa

8. Competitive Landscape

• Company Profile
  • Roche
• Company Highlights
• Product Portfolio
• Key Developments
• Financial Performance
• Strategies
  • Qiagen
  • Abbott Laboratories
  • BD
  • Hologic
  • Seegene
  • Arbor Vita
  • Femasys
  • Cooper Surgical
  • Analyst Views

9. Section

• References
• Research Methodology
• About us